Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Sale of 1,283 RARE shares, $17.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 1,283 | $17.4K |
| Sep 8, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 161 | $2.3K |
| Apr 24, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 20,241 | n/a |
| Mar 3, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Tax Withholding | 148 | $3.5K |
| Dec 30, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 85 | $2.9K |
| Sep 19, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 64 | $1.9K |
| Sep 8, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 84 | $2.6K |
| Mar 5, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 9,392 | n/a |
| Dec 11, 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Gift | 648 | n/a |
| Sep 18, 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 700 | n/a |